Predicting Manifest Astigmatism in Keratoconus Patients.

January 27, 2025 updated by: Harry Roberts, Royal Devon and Exeter NHS Foundation Trust

Predicting Manifest Astigmatism in Keratoconus Patients: a Machine Learning Approach Using Corneal Topography.

The cornea of the human eye has several functions. It is transparent to allow light into the eye and its shape focuses the incoming light onto the retina. The cornea is responsible for two-thirds of this focusing, while the human lens accounts for the remaining third.

Keratoconus is a condition with onset in the second to third decades of life, where the cornea warps into an irregular shape. This irregularity reduces vision due to blurring of the image focused on the retina. Only partial improvement is achievable with traditional glasses because the corneal shape becomes irregular.

The glasses prescriptions of patients with keratoconus often differ significantly from the measurements obtained from the cornea in a clinical setting. The predictability of the magnitude and variability of this disparity is poorly understood. As a result, determining the optimal glasses prescription for achieving the best vision correction often involves a time-consuming trial-and-error approach. Improved predictability could reduce the time required to identify the optimal glasses prescription, thereby increasing productivity. For surgical patients, better predictability would enable surgeons to select lenses that provide superior vision outcomes after treatment. In the optometry clinic at the West of England Eye Unit, a database of over 800 patients with glasses prescriptions and corresponding corneal scans has been compiled by the investigators. This is a sufficient dataset to train and assess the prediction accuracy of machine learning models (AI) of glasses measurements using corneal scan parameters as predictor variables.

Study Overview

Detailed Description

Keratoconus is one of the leading causes of visual impairment worldwide. Its main therapeutic options include corneal cross-linking, intracorneal ring segments, penetrating keratoplasty, and lamellar keratoplasty.

Keratoconus is a progressive condition with onset in childhood, resulting in increasing irregularity of corneal shape. The cornea's role is to refract incoming light to focus it onto the retina to produce a sharp image. Irregularity of the cornea degrades this image. Keratoconus develops throughout the second and third decades of life and usually stabilises in the fourth decade. It leads to progressive vision loss. When detected early, progression can be halted or stabilised with collagen cross-linking treatment. Once the condition progresses to impair the quality of vision, rigid contact lenses or surgical procedures are often required for correction. Spectacles and soft contact lenses are frequently inadequate due to the cornea's irregular shape in keratoconus.

Surgical approaches to keratoconus that do not involve corneal transplantation include implantable collamer lenses (ICL) or toric intraocular lenses (tIOL). There is little published evidence on the use of these approaches, and no consensus exists regarding the extent of astigmatism to correct or the proper axis of astigmatism to select.

In addition to lower-order aberrations (such as those correctable by spectacles, including short-sightedness, long-sightedness, and astigmatism), higher-order aberrations are present, which cannot be corrected with glasses. Due to irregular corneal astigmatism and higher-order aberrations, accurate refraction is often challenging in patients with keratoconus. Eyes with keratoconus exhibit approximately five to six times more higher-order aberrations than normal eyes, particularly vertical coma. The manifest refractive cylinder (the astigmatism component in a glasses prescription) includes both regular and irregular astigmatism. Additionally, the axis of astigmatism in the prescription often differs significantly from the topometric axis derived from three-dimensional corneal imaging. In managing astigmatism for suitable patients, such as those receiving implantable collamer lenses (ICL) or toric intraocular lenses (tIOL), it is crucial to better understand the shape factors contributing to manifest refraction. Improved understanding can help neutralise post-operative refraction more effectively and achieve greater predictability. For non-surgical patients, determining the optimal glasses prescription to achieve the best vision correction often involves a time-consuming trial-and-error process. Improved predictability could reduce the time required to identify the optimal prescription, thereby enhancing productivity and patient care.

The aim of this study is to use data already collected from more than 800 patients to compare topographic elements (three-dimensional modelling of corneal shape), such as anterior and posterior curvatures and higher-order aberrations, to subjective manifest astigmatism (the amount of astigmatism in the glasses prescription) in keratoconic eyes. The impact of keratoconus severity on disparities between these methods will also be evaluated.

Study Type

Observational

Enrollment (Estimated)

800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Devon
      • Exeter, Devon, United Kingdom, EX2 5DW
        • West of England Eye Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

- Keratoconus patients at the West of England Eye Unit in Exeter, United Kingdom

Description

Inclusion Criteria:

  • All patients with a diagnosis of keratoconus who have had topography performed at the West of England Eye Unit with contemporaneous manifest refraction.

Exclusion Criteria:

  • Poor quality topography scans.
  • History of ocular surgery.
  • Age <16 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The root mean squared error (RMSE) of the machine learning model's predictions for the patient's manifest astigmatism.
Time Frame: Baseline

The primary outcome measure will be derived from the machine learning regression analysis, with demographic and keratometry values serving as predictor variables (X) and manifest astigmatism as the outcome variable (Y).

For each patient, the earliest Pentacam scan recorded during the study period, for which a manifest astigmatism measurement exists on the same day, will be used.

Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shapley values for each predictor variable in the best-performing machine learning model.
Time Frame: Baseline

Shapley values provide insights into the importance of each variable in the model's predictions. This approach helps identify the relationships between corneal topographic factors and manifest astigmatism in keratoconus patients. These values will be found during the machine learning analysis.

For each patient, the earliest Pentacam scan recorded during the study period, for which a manifest astigmatism measurement exists on the same day, will be used.

Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Estimated)

May 31, 2025

Study Completion (Estimated)

May 31, 2025

Study Registration Dates

First Submitted

January 20, 2025

First Submitted That Met QC Criteria

January 27, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 27, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To avoid publishing personally identifiable information. Instead, summary statistics of the population analysed will be made available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratoconus

Clinical Trials on Glasses

Subscribe